Tawam Hospital in affiliation with Johns Hopkins Medicine, announces that it will organise the second edition of its industry leading Emirates Oncology Conference on November 14-16, 2013 in collaboration with the Abu Dhabi Health Services Co. (SEHA). The conference will take place at Emirates Palace, Abu Dhabi, under the theme ‘Setting Higher Standards in Cancer Care’. It will bring together almost 1,000 regional and local specialists in cancer research, treatment, and care to discuss and debate the latest advances in the field of oncology.

The three-day conference will focus on advancements in breast cancer, palliative care, gastrointestinal, gynaecological, urology, and pulmonary oncology; haematology; with specific sessions dedicated to advancements in paediatric oncology treatment. The programme this year will also include distinct sessions on Clinical Trials and Cancer Registry highlighting Tawam’s position as the reference centre for oncology in the region. An invited audience of surgeons, physicians, nurses, and other healthcare professionals involved with the practice of oncology from the UAE, GCC, and the Middle East are expected to attend the conference.

World-renowned researchers and practitioners of oncology that are expected to attend the conference include Dr. Bernard Nordlinger of Hôp. Ambroise Paré, Dr. Mehra Golshan of Dana Farber Brigham and Women’s Cancer Center, Dr. John Yves Douillard of ICO R. Gauducheau, and Dr. Richard R. Barakat, from Memorial Sloan Kettering Cancer Center. Well known oncology specialists from the region who will share their insights into research and treatment include Dr. Mohammed Jaloudi of Tawam Hospital, Conference Chair, Dr. Nagi S. El Saghir of American University of Beirut, Dr. Shouki Bazarbashi of King Faisal Specialist Hospital and Research Centre and Dr. Yasser Abd El Kader and Dr. Hamdy Abdel Azim, both from Cairo University.

Gregory Schaffer, CEO, Tawam Hospital said, "The annual Emirates oncology conference confirms our reputation as a regional leader in cancer care and showcases the advanced capabilities and that we have built up over the past 30 years. As we share our local and regional insights into that practice of oncology with global experts, we will also set an agenda for our research effort into cancer care and treatment for next year. This two way process of knowledge sharing that helps develop the practice of oncology is the biggest benefit that our conference brings to the UAE and to the region. We have seen keen interest for this year’s conference from senior and noted professionals from the region wide practice of cancer care and treatment and are assured of its success."

Dr. Mohammed Jaloudi, Chair, Emirates Oncology Conference added, "We set the bar high last year and expect to maintain those standards with our focused pursuit of excellence. The program has been designed such that during the three-day conference almost all the key sub-specialties of oncology will be discussed. Presentations made by well-known global experts and panel discussions will update attendees with information on best practice and the latest developments in cancer research, diagnosis and treatment. It will help develop their clinical abilities and allow them to interact with thought leaders in the field of oncology.”

The three-day conference begins Thursday, November 14, 2013 and the closing session will begin on Saturday November 16, at 8 am. Registration is open now through http://www.emiratesoncology.ae/.

Tawam Hospital is part of the SEHA Health System and is owned and operated by SEHA, which is responsible for the curative activities of all the public hospitals and clinics in the Emirate of Abu Dhabi.

We accept Guest Posts

Download the Dubai City Guide iPhone mobile app

DubaiCityGuide.com is owned and managed by Cyber Gear